Grown Rogue International (GRUSF) Net Income Growth (3y) (2012 - 2023)
Grown Rogue International (GRUSF) Net Income Growth (3y) (2012 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.60 Bn | 87.73 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.83 Bn | 32.09 Bn | 1.97 Bn | 51.28% |
| 3 | Zoetis | 32.46 Bn | 30.52 Bn | 1.62 Bn | 2.94% |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn | -62.58% |
| 5 | United Therapeutics | 23.14 Bn | 20.99 Bn | 648.10 Mn | 4.50% |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.28 Bn | 18.48 Bn | 1.16 Bn | -7.75% |
| 8 | Neurocrine Biosciences | 17.78 Bn | 16.46 Bn | 800.70 Mn | 66.11% |
| 9 | Elanco Animal Health | 12.61 Bn | 12.18 Bn | 785.00 Mn | -17.90% |
| 10 | Grown Rogue International | 99.97 Mn | 86.26 Mn | 3.96 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2023 | -96.27% |
| Jul 31, 2023 | 29.16% |
| Apr 30, 2023 | -30.11% |
| Jan 31, 2023 | 23.51% |
| Jan 31, 2022 | -70.53% |
| Oct 31, 2021 | 4,023.56% |
| Jul 31, 2021 | 55.81% |
| Jan 31, 2021 | 9.36% |
| Aug 31, 2018 | 52.21% |
| May 31, 2018 | -73.64% |
| Feb 28, 2018 | -26.21% |
| Nov 30, 2017 | 29.42% |
| May 31, 2017 | -0.91% |
| Feb 28, 2017 | 42.26% |
| Nov 30, 2016 | 84.98% |
| Aug 31, 2016 | -73.12% |
| May 31, 2016 | -101.99% |
| Feb 29, 2016 | -140.46% |
| Nov 30, 2015 | -248.83% |
| Aug 31, 2015 | -158.39% |